Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 09:58 am Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
RTW Investments, LP | 1,998,750 3.170% |
740,000 (+58.79%) |
Filing History |
| 2021-02-11 4:52 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BIOTECHNOLOGY VALUE FUND L P | 3,114,250 4.700% |
3,114,250 (New Position) |
Filing History |
| 2021-02-02 1:02 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Atlas Venture Fund IX L.P. | 916,196 8.080% |
916,196 (New Position) |
Filing History |
| 2020-12-03 09:29 am Purchase |
2020-11-06 | 13G | Cogent Biosciences, Inc. COGT |
RTW Investments, LP | 1,258,750 9.990% |
1,258,750 (New Position) |
Filing History |
| 2020-11-19 4:05 pm Purchase |
2020-11-09 | 13G | Cogent Biosciences, Inc. COGT |
Logos Global Management LP | 1,907,971 9.990% |
1,907,971 (New Position) |
Filing History |
| 2020-11-19 1:55 pm Purchase |
2020-11-09 | 13G | Cogent Biosciences, Inc. COGT |
Ally Bridge Group (NY) LLC | 1,420,500 8.030% |
1,420,500 (New Position) |
Filing History |
| 2020-09-08 3:10 pm Purchase |
2020-08-27 | 13G | UNUM THERAPEUTICS INC UMRX |
Logos Global Management LP | 1,928,291 5.000% |
1,928,291 (New Position) |
Filing History |
| 2020-08-18 7:20 pm Purchase |
2020-08-13 | 13G | UNUM THERAPEUTICS INC UMRX |
Venrock Healthcare Capital Partners II, L.P. | 4,355,273 11.400% |
2,468,055 (+130.78%) |
Filing History |
| 2020-07-20 4:07 pm Purchase |
2020-07-09 | 13G | UNUM THERAPEUTICS INC UMRX |
Venrock Healthcare Capital Partners II, L.P. | 1,887,218 5.000% |
1,887,218 (New Position) |
Filing History |
| 2020-07-16 5:11 pm Purchase |
2020-07-06 | 13G | UNUM THERAPEUTICS INC UMRX |
BIOTECHNOLOGY VALUE FUND L P | 4,154,000 9.990% |
4,154,000 (New Position) |
Filing History |
| 2020-07-16 4:12 pm Purchase |
2020-07-06 | 13G | UNUM THERAPEUTICS INC UMRX |
Ridgeback Capital Investments L.P. | 2,400,000 6.200% |
2,400,000 (New Position) |
Filing History |
| 2020-07-09 5:32 pm Purchase |
2020-07-06 | 13D | UNUM THERAPEUTICS INC UMRX |
Fairmount Funds Management LLC | 7,482,460 19.990% |
7,482,460 (New Position) |
Filing History |